SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (27735)1/31/1999 1:04:00 AM
From: bob zagorin  Respond to of 32384
 
thanks, tex. good point.

OT. did you sell any ifmx before the report?



To: Arthur Radley who wrote (27735)1/31/1999 1:02:00 PM
From: Bryce Elkins  Respond to of 32384
 
TD - I agree on your point wrt Targretin; that's the reason I hold a position in LGND. The other drugs are important to cash flow, but share appreciation will really occur if Targretin in humans produces the results it did in the lab rats :-)

Ble


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News